InvestorsHub Logo
Followers 971
Posts 382998
Boards Moderated 6
Alias Born 06/24/2011

Re: None

Thursday, 10/11/2018 12:27:47 PM

Thursday, October 11, 2018 12:27:47 PM

Post# of 2804248
$PRVCF now developing the first, sustained-release, CBD-based nose-to-brain delivery system that will provide relief across a range of indications from pain, inflammation, seizures, and neurological disorders. Our proprietary nasal formulations will also be designed to be universally-patient friendly, meaning formulations that can be used in children and adults alike.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.